Survey on medication information leaflets for organ transplant patients
Official title: Development and Validation of Materials for the Pharmaceutical Care of Organ Transplant Recipients in Community Pharmacy: Survey on the Evaluation of Medication Information Leaflets for Organ Transplant Patients
Run by Universität Münster · NCT06652919 · Data updated 2026-11-12
This study is trying to find out what organ transplant patients and their caregivers think about the medication information leaflets to make them clearer and more helpful.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Universität Münster Academic / other |
| Locations | 1 site (Münster, North Rhine-Westphalia) |
| Status | Recruiting |
| Started | November 6, 2024 |
| Main results expected | January 2025 |
| Study ends | March 2025 |
| Registry record updated | November 8, 2024 |
| Trial ID | NCT06652919 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adult organ transplant patients or their caregivers who are German-speaking and currently taking immunosuppressants.
✕Probably not a fit
Patients who are not able to provide consent, non-German speakers, those under 18 years old, or individuals who have undergone transplantation but are no longer taking immunosuppressants may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to gather feedback from organ transplant patients and their caregivers regarding the medication information leaflets developed for them. Using a questionnaire, the study will assess the effectiveness and clarity of these leaflets to ensure they meet the specific needs of this patient population. The feedback will be used to refine the content of the leaflets, enhancing patient understanding and adherence to their medication regimens. The study highlights the importance of tailored pharmaceutical care for organ transplant recipients.
Why it matters
Potential benefit: If successful, this study could improve patient understanding and adherence to medication regimens, leading to better health outcomes for organ transplant recipients.
How similar studies have gone: While this approach is focused on patient feedback for medication leaflets, similar studies have shown that tailored information can significantly enhance patient adherence and safety in medication management.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients who have undergone solid organ transplantation (kidney, liver, heart, lung) * Caregivers or family members of organ transplant patients * German-speaking individuals * adult Exclusion Criteria: * Individuals who are not able to provide consent * Non-German-speaking individuals * under 18 years old * Patients who have undergone organ transplantation and are no longer taking immunosuppressants
Where it's running
-
Institute of Pharmaceutical and Medicinal Chemistry, Clinical Pharmacy, University of Münster
Münster, North Rhine-Westphalia, Germany Recruiting
Study contacts
- Study coordinator: Li-Yun Chen
- Email: liyun.chen@uni-muenster.de
- Phone: +49 (0) 251 83-32173
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Education and a smartphone app to help organ transplant patients manage life, meds, and symptoms
A smartphone app plus teaching materials are tested to see if they improve quality of life and adherence to immunosuppressive therapy for adults who have had a liver or kidney transplant.
-
Collection of biological materials from organ transplant patients
This study is collecting samples from organ transplant patients to help researchers learn more about why transplants sometimes fail and to find better ways to detect rejection and other related issues.
-
Improving long-term survival for organ transplant patients
This study is testing ways to improve the long-term success of organ transplants by personalizing care and collecting samples from patients to better predict and prevent transplant rejection.
-
Developing a library of samples from organ transplant patients
This study is collecting blood, tissue, and urine samples from organ transplant patients and healthy volunteers to see how their bodies respond to transplant treatments and medications.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.